DLBCL Video Channel
Explore the latest insights and summaries from experts in DLBCL.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in DLBCL and HL
FEATURING
Julie Erika Haydu
- 310 views
- June 5, 2024
- 3
Dipenkumar Modi
Current Management of DLBCL From Frontline to Relapsed Disease
- 334 views
- June 5, 2024
Gerardo Musuraca
Managing R/R DLBCL: Bispecific Antibodies and the "Surface Epitopes Strategy"
- 72 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,289 views
- June 19, 2024
- 2
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 240 views
- July 8, 2024
SOHO Brazil 2024
Has the 1L SoC Truly Changed in Advanced Stage DLBCL?
FEATURING
Andrew Zelenetz
- 567 views
- July 11, 2024
- 3
SOHO Brazil 2024
Summary of Updates in R/R DLBCL Treatment
FEATURING
Alvaro Alencar
- 109 views
- July 11, 2024
SOHO Brazil 2024
DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We Treat Them?
FEATURING
Andrew Zelenetz
- 126 views
- July 11, 2024
SOHO Brazil 2024
What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy in LBCL?
FEATURING
Andrew Zelenetz
- 57 views
- July 11, 2024
UChicago Medicine
How to Assess and Treat Elderly Patients With DLBCL
FEATURING
Stefano Luminari
- 76 views
- July 22, 2024
UChicago Medicine
Sequencing of Bispecifics With Other Therapies in DLBCL
FEATURING
Elizabeth Budde
- 347 views
- July 29, 2024
Integrity CE
Treatment Updates and Management of Non-Hodgkin Lymphomas
FEATURING
Danielle Wallace,
Matthew Cortese
- 103 views
- August 7, 2024
- 1
MyCancerHaven
Recent Updates on Liso-Cel in R/R DLBCL & MCL
FEATURING
Ravi Vij,
Forat Lutfi
- 44 views
- August 30, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: HL, DLBCL, MCL
FEATURING
Alexandra Rojek
- 127 views
- September 4, 2024
- 2
Houston Methodist
What's Current in Immunotherapy in DLBCL and FL
FEATURING
Amitkumar Mehta
- 104 views
- September 10, 2024
Yale Cancer Center
Caring for Patients With Lymphoma: Using Guidelines to Improve Quality of Care
FEATURING
Scott Huntington,
Eric Winer
- 77 views
- September 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 467 views
- September 23, 2024
- 2
Patrizia Mondello
Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLBCL
- 184 views
- September 30, 2024
Sarah Rutherford
Optimizing 2L DLBCL Treatment Strategies for CAR-T Ineligible Patients
- 66 views
- October 15, 2024
University of Colorado Division of Hematology
DLBCL: How Do We Choose Initial Therapy?
FEATURING
Caroline Pearson
- 24 views
- October 21, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Updates in DLBCL: Insights on Treatment and Research
FEATURING
John Lister
- 34 views
- October 21, 2024
- 1
Yale Cancer Center
Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL
FEATURING
Tarsheen Sethi
- 185 views
- October 21, 2024
- 1
Yale Cancer Center
DLBCL Case Discussion: Strategies for 3L Management
FEATURING
Scott Huntington,
Iris Isufi
- 40 views
- October 22, 2024
- 1
Vanderbilt University Medical Center (VUMC)
Updates in CAR-T Therapy for Aggressive Lymphomas
FEATURING
Bhagirathbhai Dholaria
- 97 views
- October 23, 2024
- 1
Joseph Mikhael
The Relapsed and Refractory MM Patient: When Immune Approaches Are Ineffective
- 100 views
- November 10, 2024
- 2
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
FEATURING
Manali Kamdar
- 252 views
- April 8, 2024
- 1
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do and Know in Community Oncology Practice
FEATURING
Tycel Phillips
- 152 views
- April 23, 2024
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lymphomas
FEATURING
Sonali Smith
- 665 views
- April 23, 2024
- 7
Indy Hematology Review
2024 Updates on Understanding & Managing Immune Effector Cell Toxicities in Hematologic Malignancies
FEATURING
David Reeves
- 243 views
- April 30, 2024
- 2
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
FEATURING
Pallawi Torka
- 376 views
- May 2, 2024
MyCancerHaven
Frontline DLBCL Treatment Approaches
FEATURING
Ravi Vij,
Hua-Jay Cherng
- 321 views
- May 13, 2024
- 1
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL
FEATURING
Shalin Kothari
- 132 views
- May 13, 2024
UChicago Medicine
Improving Lymphoma Outcomes: Optimizing Trial Design, Using Surrogate Endpoints, and Incorporating Guidelines
FEATURING
Andrew Zelenetz
- 106 views
- July 22, 2024
- 1
University of Colorado Cancer Center
Managing R/R LBCL Patients Treated With Pola-R-CHP in 1L and Are CAR-T Ineligible
FEATURING
Manali Kamdar
- 111 views
- November 21, 2024
- 2
UNC Lineberger Comprehensive Cancer Center
2024 Updates in the Management of DLBCL, FL, and HL
FEATURING
Anne Beaven
- 36 views
- November 26, 2024
- 1
Moffitt Cancer Center
R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?
FEATURING
Aleksandr Lazaryan
- 332 views
- March 11, 2024
- 1
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Lymphoid Diseases
- 46 views
- March 11, 2024
Scripps Health
New Updates in Frontline DLBCL
FEATURING
Loretta Nastoupil
- 704 views
- March 21, 2024
- 5
Scripps Health
Update in the Treatment of R/R DLBCL
FEATURING
Charalambos Andreadis
- 234 views
- March 28, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: B-Cell Lymphoma
FEATURING
Loretta Nastoupil
- 435 views
- March 29, 2024
- 3
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Aggressive B-Cell Lymphomas
FEATURING
Grzegorz Nowakowski
- 395 views
- March 29, 2024
- 3
Megan Melody
Sequencing Cellular Therapy and Bispecific Antibodies in DLBCL
- 112 views
- December 2, 2024
- 4
Grzegorz Nowakowski
Current Approaches and Ongoing Trials in Frontline DLBCL Treatment
- 16 views
- December 13, 2024
Louisville Hematology Highlights
2024 Updates on Management of DLBCL
FEATURING
John Leonard
- 98 views
- December 13, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Optimizing Tafa-Len in R/R DLBCL - GELTAMO Real-World Study
FEATURING
Antonio Gutierrez
- 16 views
- December 16, 2024
- 1
Remy Dulery
Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy
- 19 views
- December 17, 2024
Therapeutic Agents
Dipenkumar Modi
Current Management of DLBCL From Frontline to Relapsed Disease
- 334 views
- June 5, 2024
Rush University Medical Center
Off the Shelf CARs for DLBCL: Myths and Facts
FEATURING
Veronika Bachanova
- 28 views
- June 6, 2024
Gerardo Musuraca
Managing R/R DLBCL: Bispecific Antibodies and the "Surface Epitopes Strategy"
- 72 views
- June 17, 2024
Wojciech Jurczak
Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial
- 343 views
- June 26, 2024
SOHO Brazil 2024
Summary of Updates in R/R DLBCL Treatment
FEATURING
Alvaro Alencar
- 109 views
- July 11, 2024
SOHO Brazil 2024
What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy in LBCL?
FEATURING
Andrew Zelenetz
- 57 views
- July 11, 2024
Vanderbilt University Medical Center (VUMC)
CAR-T for Lymphoma: The Impact of Cell Therapy and Future Challenges
FEATURING
Sattva Neelapu
- 27 views
- July 18, 2024
UChicago Medicine
The Next Frontier of Targeted Therapy in Lymphoma
FEATURING
Kami Maddocks
- 236 views
- July 22, 2024
UChicago Medicine
Exploring the Value of PI3K in Lymphoma Treatment
FEATURING
Changchun Deng
- 18 views
- July 22, 2024
UChicago Medicine
Targeting BTK in B-Cell NHL: Pros and Cons of Inhibitors and Degraders
FEATURING
Adam Kittai
- 48 views
- July 22, 2024
- 1
UChicago Medicine
Bispecifics for LBCL: Guidance for Management of Toxicities in the Community
FEATURING
Jennifer Crombie
- 170 views
- July 29, 2024
- 3
UChicago Medicine
The Evolving Role for Bispecific Antibodies in B-Cell Lymphoma
FEATURING
Tara Mccabe
- 43 views
- July 29, 2024
Yasmin Karimi
FDA Approval of Epcoritamab in R/R FL: What You Need to Know
- 283 views
- August 12, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Overview of Biscpecific Antibodies in Hematologic Malignancies
FEATURING
Bahar Uncu Ulu
- 50 views
- August 15, 2024
Joseph McGuirk
Liso-Cel in R/R DLBCL: Real-World Insights From the Cell Therapy Consortium
- 53 views
- August 27, 2024
MyCancerHaven
Experts Discuss the Use of CAR-T in 2L DLBCL
FEATURING
Ravi Vij,
Dipenkumar Modi
- 66 views
- August 30, 2024
MyCancerHaven
Recent Updates on Liso-Cel in R/R DLBCL & MCL
FEATURING
Ravi Vij,
Forat Lutfi
- 44 views
- August 30, 2024
Houston Methodist
What's Current in Immunotherapy in DLBCL and FL
FEATURING
Amitkumar Mehta
- 104 views
- September 10, 2024
University of Colorado Department of Medicine
Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Going?
FEATURING
Jonathan Gutman
- 294 views
- September 19, 2024
- 2
Patrizia Mondello
Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLBCL
- 184 views
- September 30, 2024
Amit Mehta
Tafasitamab/Lenalidomide for DLBCL: Which Patients and What to Expect
- 127 views
- October 9, 2024
- 3
Sarah Rutherford
Optimizing 2L DLBCL Treatment Strategies for CAR-T Ineligible Patients
- 66 views
- October 15, 2024
Vanderbilt University Medical Center (VUMC)
Updates in CAR-T Therapy for Aggressive Lymphomas
FEATURING
Bhagirathbhai Dholaria
- 97 views
- October 23, 2024
- 1
Joseph Mikhael
The Relapsed and Refractory MM Patient: When Immune Approaches Are Ineffective
- 100 views
- November 10, 2024
- 2
MyCancerHaven
How I Use CAR T-Cells in Lymphoma
FEATURING
Ravi Vij,
Abhinav Deol
- 61 views
- April 10, 2024
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do and Know in Community Oncology Practice
FEATURING
Tycel Phillips
- 152 views
- April 23, 2024
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lymphomas
FEATURING
Sonali Smith
- 665 views
- April 23, 2024
- 7
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL
FEATURING
Shalin Kothari
- 132 views
- May 13, 2024
Yale Cancer Center
Updates on Cellular Therapy Advances in Lymphoma
FEATURING
Iris Isufi
- 86 views
- May 15, 2024
Rush University Medical Center
Advancements in Richter's Transformation: Novel Agents and Cellular Therapies
FEATURING
Farrukh Awan
- 47 views
- June 13, 2024
Juan Pablo Alderuccio
Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial
- 229 views
- July 8, 2024
- 1
Moffitt Cancer Center
R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?
FEATURING
Julio Chavez
- 826 views
- March 4, 2024
- 4
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Lymphoid Diseases
- 46 views
- March 11, 2024
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Cell Therapy
FEATURING
Marcos de Lima
- 183 views
- March 26, 2024
- 3
Zachariah DeFilipp
Axatilimab in Chronic GVHD: Updates From the AGAVE-201 Study
- 187 views
- March 27, 2024
Scripps Health
Update in the Treatment of R/R DLBCL
FEATURING
Charalambos Andreadis
- 234 views
- March 28, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Aggressive B-Cell Lymphomas
FEATURING
Grzegorz Nowakowski
- 395 views
- March 29, 2024
- 3
UChicago Medicine
Understanding CRISPR and Gene Editing in the Treatment of Heme Malignancies and Blood Disorders
FEATURING
Alan Cooper
- 255 views
- July 29, 2024
Yale Cancer Center
The Role of Radiation in Patients Undergoing CAR T-Cell Therapy for Aggressive Lymphomas
FEATURING
Timothy Robinson
- 8 views
- October 28, 2024
UChicago Medicine Jonas Center Cellular Therapy Symposium
Avoiding Alloreactive T-Cells to Enable Off-the-Shelf Therapy for Lymphoma
FEATURING
Cliona Rooney
- 5 views
- December 4, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Optimizing Tafa-Len in R/R DLBCL - GELTAMO Real-World Study
FEATURING
Antonio Gutierrez
- 16 views
- December 16, 2024
- 1
Diagnostics & Biomarkers
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CLL Case Discussion: Diagnosis and Managment of Richter Syndrome
FEATURING
Mohammed Kamil Al Qayyim
- 9 views
- October 15, 2024
University of Colorado Division of Hematology
DLBCL: Principles of Diagnosis, Prognosis and Staging
FEATURING
Caroline Pearson
- 37 views
- October 15, 2024
Stanford Medicine
Current Clinical Utility of ctDNA in Lymphomas
FEATURING
Joseph Schroers-Martin
- 23 views
- November 10, 2024
- 1
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lymphomas
FEATURING
Sonali Smith
- 665 views
- April 23, 2024
- 7
UChicago Medicine
Improving Lymphoma Outcomes: Optimizing Trial Design, Using Surrogate Endpoints, and Incorporating Guidelines
FEATURING
Andrew Zelenetz
- 106 views
- July 22, 2024
- 1
UChicago Medicine
Understanding AI and Computational Oncology: Applications in Lymphoma
FEATURING
Frederick Howard
- 44 views
- July 29, 2024
Disease Overview
Yale Cancer Center
Caring for Patients With Lymphoma: Using Guidelines to Improve Quality of Care
FEATURING
Scott Huntington,
Eric Winer
- 77 views
- September 11, 2024
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 25 views
- October 7, 2024
UChicago Medicine
Reducing Disparities in Lymphoma Care With a Focus on DLBCL
FEATURING
Christopher Flowers
- 57 views
- July 29, 2024
Case Studies
UChicago Medicine
Hematopathology Tumor Board: Case Studies and Diagnostic Challenges in Lymphoma Management
- 245 views
- July 18, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
DLBCL Case Discussion: GCB Disease With CNS Involvement
FEATURING
Ebru Pekgüç
- 21 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CLL Case Discussion: Diagnosis and Managment of Richter Syndrome
FEATURING
Mohammed Kamil Al Qayyim
- 9 views
- October 15, 2024
University of Colorado Division of Hematology
DLBCL: Principles of Diagnosis, Prognosis and Staging
FEATURING
Caroline Pearson
- 37 views
- October 15, 2024
University of Colorado Division of Hematology
DLBCL Cases: Managing Treatment-Related TLS and Hypersensitivity Reactions
FEATURING
Caroline Pearson
- 12 views
- October 16, 2024
Yale Cancer Center
DLBCL Case Discussion: Strategies for 3L Management
FEATURING
Scott Huntington,
Iris Isufi
- 40 views
- October 22, 2024
- 1
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
FEATURING
Pallawi Torka
- 376 views
- May 2, 2024
Vanderbilt University Medical Center (VUMC)
Age Limits in Stem Cell Transplants and Cell Therapy
FEATURING
Reena Jayani
- 66 views
- July 22, 2024
